MYX 0.66% $4.60 mayne pharma group limited

Ann: Mayne Pharma announces sale of Metrics Contract Services, page-38

  1. 12,976 Posts.
    lightbulb Created with Sketch. 1363
    Proceeds after all costs A$636m
    Interest bearing debt A$390m

    Remaining proceeds A$246m

    Spec dividend 7cents/share A$122m (my speculation)

    Cash remaining A$124m to be used to fund growth

    Cheers......D
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.